MedTrace Logo

CommunICation of bEnefit Risk Information: an Online Randomised Controlled Trial

NCT05917639 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2178

Last updated 2023-12-18

No results posted yet for this study

Summary

How health-related information is communicated affects what is understood and might influence how people make decisions and how confident they feel in participating in clinical shared decision-making.

The CICERO trial will compare three different communication tools providing information on fictional interventions for a common medical problem (i.e. social anxiety disorder) both in terms of how well interventions work (benefit) and also possible harms associated (risk). The three communication tools ("Summary of Findings table", "Kilim plot", and "Vitruvian plot") differ in how they present information: exclusively written, primarily written and partially graphical, or mixed written and visual. Each participant will be asked to go through one clinical scenario.

The investigators will ask participants to familiarise themselves with the tool they have been allocated to (either a plot or a table) and then answer some validated questionnaires to measure how useful and efficient the communication strategy was.

The entire study occurs online in a single study session (about 20 minutes).

The results of the CICERO trial will inform how to communicate research findings to the general population, facilitating their implementation in clinical shared decision-making.

Conditions

  • Knowledge, Attitudes, Practice
  • Literacy
  • Confidence, Self

Interventions

DEVICE

Vitruvian plot

Visual (magnitude, uncertainty) and written (magnitude) communication tool / interventional decision-making aid tool

DEVICE

Kilim plot

Visual (uncertainty) and written (magnitude) communication tool / interventional decision-making aid tool

DEVICE

Summary of findings table

Written (magnitude, uncertainty) communication tool / interventional decision-making aid tool

Sponsors & Collaborators

  • University of Oxford

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-05-31
Primary Completion
2023-11-27
Completion
2023-11-27

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05917639 on ClinicalTrials.gov